Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Shared Decision Making in Hemophilia Patient CareRelease Date:Quality Improvement Rare Disease China Optimizing HRRm Testing and Workflow Integration in mCSPCRelease Date:Quality Improvement, Research Oncology Canada Driving Timely Biomarker Testing to Optimize Treatment Decisions for Colorectal Cancer Patients Across CanadaRelease Date:Partner: Colorectal Cancer Canada (CCC)Quality Improvement, Research Oncology Canada Optimizing Disease Management to Improve Alopecia Areata Quality of CareRelease Date:Quality Improvement Inflammation & Immunology China Providing Appropriate Medical Care for IBD PatientsRelease Date:Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)Quality Improvement Inflammation & Immunology Japan Fostering Educational Initiatives for ALK+ Metastatic Non-Small Cell Lung Cancer(mNSCLC) Tyrosine Kinase Inhibitors(TKI) TherapyRelease Date:Education Oncology Canada 2026 Headache Medicine Fellowship - USRelease Date:Fellowship Internal Medicine USA Advances in Migraine ManagementRelease Date:Education Internal Medicine USA Real-World Evidence of SUL-DUR on Special Populations with CRAB InfectionRelease Date:Research Inflammation & Immunology China Optimizing Atopic Dermatitis Quality of Care and Best Practice at Local LevelRelease Date:Quality Improvement Inflammation & Immunology China Addressing HCP Knowledge Gaps in Baseline Assessments for Adults with Ulcerative Colitis Starting S1P Receptor Modulator TherapyRelease Date:Education Inflammation & Immunology USA Use of AI to Improve Speed/Precision of Treatment Selection & Clinical Management for Patients w/ Invasive Mold InfectionsRelease Date:Education Hospital Australia, China, France, Germany, Italy, Korea, Spain, Taiwan, United Kingdom Quality improvement strategies to enhance quality of life in ALK-positive lung cancer patientsRelease Date:Quality Improvement Oncology Spain Maintenance Therapy in HER2+ Metastatic Breast Cancer (MBC)Release Date:Education Oncology USA Efforts to Improve Quality of Migraine CareRelease Date:Partner: The Japanese Headache SocietyQuality Improvement Internal Medicine Japan Enhancing HCP Education in Adult Vaccination against Respiratory InfectionsRelease Date:Education Vaccines Austria, Belgium, Greece, Ireland, Luxembourg, Portugal, Switzerland Migraine and Women’s HealthQuality Improvement, Research Internal Medicine USA Real World Evidence on clinical outcomes with Aztreonam-Avibactam (ATM-AVI)Release Date:Research Inflammation & Immunology All Improving Health Outcomes in Patients with ATTR-CM Through the Development of a Shared Decision-Making Tool (Decision Aid)Release Date:Research Rare Disease USA Capacity Building for Clinical Trials in Sickle Cell Disease (SCD) - Education for Healthcare ProfessionalsRelease Date:Education Rare Disease USA Prostate Cancer: Best Practices for Combining Targeted Therapies in mPCRelease Date:Education Oncology USA Transthyretin Cardiac Amyloidosis FellowshipRelease Date:Research Rare Disease USA Optimizing Adult Vaccination Ecosystem in IndiaRelease Date:Quality Improvement Vaccines India Evidence Based Safety Contextualization of JAK inhibitors in the Treatment of Moderate to Severe Atopic DermatitisRelease Date:Education Inflammation & Immunology China, France, Germany, Italy, Japan, Korea, Spain, USA Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple MyelomaRelease Date:Research Oncology Spain Optimizing Clinical Care Delivery for Patients with Multiple Myeloma Receiving Bispecific AntibodiesRelease Date:Quality Improvement Oncology All Enhancing HCP Education in Maternal VaccinationRelease Date:Education Vaccines Saudi Arabia Diagnosis and Treatment of Cancer CachexiaRelease Date:Education Oncology All Evidence-Based Education on the Potential Impact of a Generic JAK Inhibitor on the Management of Rheumatologic DiseasesRelease Date:Education Inflammation & Immunology USA B-cell Maturation Antigen (BCMA) Bi-Specific Antibodies (BsAbs) in Relapsed/Refractory Multiple Myeloma (RRMM)Release Date:Education Oncology USA Education on Mechanism of Action of JAK3 and TEC Family Kinase Role in Alopecia AreataRelease Date:Education Inflammation & Immunology USA 2026 Hemophilia Fellowship – United StatesRelease Date:Fellowship Rare Disease All Pediatric Pneumococcal Disease and Serotype Distribution: Surveillance Studies in Saudi ArabiaRelease Date:Research Vaccines Saudi Arabia Optimising Ulcerative Colitis Care: Bridging Knowledge Gaps, Integrating Biomarker-Based Strategies, and Advancing EquityRelease Date:Education Inflammation & Immunology Australia Surveillance of Pneumococcal Disease Serotype Distribution in Pediatric and Adult Pneumococcal Disease in TürkiyeRelease Date:Research Vaccines Turkey Surveillance of Pneumococcal Disease Serotype Distribution in Pediatric and Adult Pneumococcal Disease in TürkiyeRelease Date:Research Vaccines Turkey Title Grant Type Focus Area Country Application Due Date Cardiac Transthyretin Amyloid (ATTR) FellowshipRelease Date:Partner: International Society of AmyloidosisFellowship Rare Disease All Early Diagnosis of Invasive Fungal Infections(Europe, Australia, New Zealand, Korea and Japan)Release Date:Research Hospital All Pfizer and RCNi – Providing Access to Learning Resources for Nurses in Emerging Markets AsiaEducation Support for the Professions Hong Kong, India, Indonesia, Malaysia, Pakistan, Philippines, Singapore, Taiwan, Thailand, Vietnam Improving Real-World Evidence & Data Generation Skills in Latin AmericaRelease Date:Education Support for the Professions All Optimizing Venous Thromboembolism Management in Latin AmericaRelease Date:Quality Improvement Internal Medicine All Alopecia Areata, Atopic Dermatitis and Vitiligo (Global)Release Date:Research Inflammation & Immunology All Relapsed/Refractory Multiple MyelomaRelease Date:Education Oncology USA Antimicrobial Stewardship (AMS) Programs to Address Health Inequities in Resource Limited SettingsRelease Date:Partner: Global Bridges at Mayo ClinicQuality Improvement Hospital All Increase HCP knowledge of Gene Therapy managementRelease Date:Education Rare Disease China Burden of Pneumococcal Disease - Analyzing Local Surveillance Data (Asia, Africa, Latin America, and Middle East)Release Date:Research Vaccines All Pre-clinical & Translational Research in Multiple MyelomaRelease Date:Research Oncology All Best Practices in HR+HER2-Metastatic Breast Cancer Medical Management Latin America,Africa,Middle East,Asia Pacific except ChinaRelease Date:Education Oncology All Acute Lymphoblastic Leukemia Peer-to-Peer Education & SupportRelease Date:Education Oncology USA PARP-inhibitor Combination Treatments in Prostate CancerRelease Date:Education Oncology USA Optimizing Patient Access to CDK 4/6 Inhibitors in the Armamentarium Against Metastatic Breast CancerRelease Date:Education Oncology USA Understanding healthcare disparities in Atopic Dermatitis and Alopecia Areata patientsRelease Date:Quality Improvement Inflammation & Immunology All ADVANCE: Global Awards for Advancing Chronic Pain ResearchRelease Date:Research Internal Medicine All Enhancing the Understanding of Health Maintenance in the Management of IBDRelease Date:Education Inflammation & Immunology USA Outpatient Management of COVID-19Release Date:Education Hospital Albania, Andorra, Armenia, Austria, Azerbaijan, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy, Kazakhstan, Kyrgyzstan, Latvia, Lithuania, Luxembourg, Macedonia, The Former Yugoslav, Malta, Moldova, Republic of, Monaco, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Slovakia (Slovak Republic), Slovenia, Spain, Sweden, Switzerland, Tajikistan, Turkey, Turkmenistan, Ukraine, United Kingdom, Uzbekistan Emerging Therapies in Alopecia Areata for Dermatologists - United StatesRelease Date:Education Inflammation & Immunology USA Virtual Programs for Rheumatology EducationRelease Date:Education Inflammation & Immunology USA 2021/2022 Global NASH ASPIRERelease Date:Research Internal Medicine All Addressing Knowledge Gaps in Alopecia Areata and Atopic Dermatitis (Global (excluding the US)Release Date:Education Inflammation & Immunology All 2021/2022 Global Obesity ASPIRERelease Date:Research Internal Medicine All Advances in Atopic Dermatitis for Dermatologists and AllergistsRelease Date:Education Inflammation & Immunology USA Geriatric Anorexia – Educational Needs AssessmentRelease Date:Education Internal Medicine USA 2021/2022 Global Cachexia ASPIRERelease Date:Research Internal Medicine All Closing Knowledge Gaps in Moderate-to-Severe Atopic Dermatitis for AllergistsRelease Date:Partner: American College of Allergy, Asthma & Immunology (ACAAI)Education Inflammation & Immunology USA Emerging Therapies for Atopic Dermatitis and Alopecia Areata for Advanced Practice Providers and Primary Care PhysiciansRelease Date:Education Inflammation & Immunology USA Pediatric Growth Hormone Deficiency EducationRelease Date:Education Rare Disease USA 2021 I&I RE-CUP-IT REal world data Competitive grant in Ulcerative colitis Program - ITalian experiencesRelease Date:Research Inflammation & Immunology Italy Multidisciplinary Gene Therapy Education - Recombinant Adeno-Associated Virus (rAAV)Release Date:Education Rare Disease All Cardiac Amyloidosis Mentor mATTch pRogramEducation Rare Disease USA Antimicrobial Stewardship (AMS) Programs in USA, Europe, Japan, South Korea, Australia and New ZealandRelease Date:Partner: Global Bridges at Mayo ClinicQuality Improvement Hospital All Assessing Gaps in BRAF Testing in Melanoma & Colorectal Cancer in Developing RegionsRelease Date:Education Oncology Algeria, Argentina, Brazil, Colombia, Iraq, Kuwait, Lebanon, Mexico, Qatar, Saudi Arabia, United Arab Emirates Astellas and Pfizer Call for Independent Medical Education Grant Applications Oncology – Prostate CancerEducation Oncology USA Optimizing Telehealth Use in CanadaRelease Date:Quality Improvement Internal Medicine Canada Improving ATTR Amyloidosis Management in SpainRelease Date:Quality Improvement Rare Disease Spain Equity in Access to Rare Disease Clinical TrialsRelease Date:Quality Improvement Rare Disease USA Management of EndometriosisEducation Internal Medicine USA 2022 Inflammatory Bowel Disease (IBD) FellowshipRelease Date:Fellowship Inflammation & Immunology USA 2022 IBD Competitive Grant ProgramRelease Date:Research Inflammation & Immunology USA Establishment of an Appropriate Network of Medical Care and Education for Axial SpondyloarthritisRelease Date:Partner: The Japan Spondyloarthritis SocietyQuality Improvement Inflammation & Immunology Japan 2022 Hemophilia ASPIRE-Africa Middle East, Asia-Pacific, & Latin AmericaRelease Date:Research Rare Disease All 2022 Global Hemophilia ASPIRERelease Date:Research Rare Disease All Management of Uterine Fibroids and EndometriosisEducation Internal Medicine USA 2022 Fellowship for Inflammatory Dermatological DiseasesRelease Date:Fellowship Inflammation & Immunology USA 2022 Rheumatology FellowshipRelease Date:Fellowship Inflammation & Immunology USA